There are currently 162 clinical trials in Columbia, South Carolina looking for participants to engage in research studies. Trials are conducted at various facilities, including University of South Carolina, Prisma Health Richland Hospital, GSK Investigational Site and Palmetto Health Richland. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Technology Interventions to Improve Outcomes After Knee Replacement
NCT04482400
Recruiting
The purpose of this study is to examine the effects of two technology interventions on health outcomes (e.g., physical activity, sedentary behavior, physical function, pain) after knee replacement at 2 and 5 months .
Gender:
All
Ages:
Between 40 years and 79 years
Trial Updated:
03/26/2024
Locations: University of South Carolina, Columbia, South Carolina
Conditions: Knee Arthroplasty
Register for Updates
Evaluating the Fade to Fitness Program: A Barbershop-based Program for Black Men
NCT06262334
Recruiting
The Fade to Fitness Program is a targeted intervention designed to improve the holistic health and quality of life among Black men. This comprehensive initiative focuses on four key health behaviors: Physical Activity, Healthy Eating, Stress Management, and Depression Management. It is grounded in psychological and social theories like Self-Determination Theory, Motivational Interviewing, and Social Cognitive Theory. The program emphasizes the importance of making informed choices, feeling comp... Read More
Gender:
Male
Ages:
Between 18 years and 90 years
Trial Updated:
03/22/2024
Locations: University of South Carolina, Columbia, South Carolina
Conditions: Health Related Quality of Life
Register for Updates
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966
Recruiting
This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with COPD and elevated cardiopulmonary risk.
Gender:
All
Ages:
Between 40 years and 80 years
Trial Updated:
03/11/2024
Locations: Research Site, Columbia, South Carolina
Conditions: COPD (Chronic Obstructive Pulmonary Disease)
Register for Updates
LOWER: Lomitapide Observational Worldwide Evaluation Registry
NCT02135705
Recruiting
This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and effectiveness of lomitapide.
Gender:
All
Ages:
All
Trial Updated:
03/11/2024
Locations: Palmetto Health, Columbia, South Carolina
Conditions: Homozygous Familial Hypercholesterolemia
Register for Updates
Determining the Optimal Amount of Structured Environments for Healthy Kids
NCT06158594
Recruiting
Studies show that virtually all increases in children's (5-12yrs) BMI occur during the summer, no matter children's' weight status (i.e., normal weight, overweight, or obese) at summer entry. Recent preliminary studies show that children engage in healthier behaviors on days that they attend summer day camps, and that BMI gain does not accelerate for these children. The proposed randomized dose-response study will identify the dose-response relationship between amount of summer programming and s... Read More
Gender:
All
Ages:
Between 5 years and 12 years
Trial Updated:
03/09/2024
Locations: University of South Carolina, Columbia, South Carolina
Conditions: Health Status Disparities, Pediatric Obesity, Ethnic Groups, Socioeconomic Factors
Register for Updates
Healthy Kids Beyond the Bell: Investigating the Impact of After-School and Summer Programs
NCT05880901
Recruiting
Nearly one in five children are obese, and disparities in overweight and obesity between children from low- and middle-to-high-income households persist despite a multitude of school-based interventions. The structured days hypothesis posits that structure within a school day plays a protective role for children against obesogenic behaviors, and, ultimately, prevents the occurrence of excessive weight gain, thus, past school-based efforts are misplaced. This study will provide access to healthy... Read More
Gender:
All
Ages:
Between 5 years and 12 years
Trial Updated:
03/09/2024
Locations: University of South Carolina, Columbia, South Carolina
Conditions: Health Status Disparities, Pediatric Obesity, Ethnic Group, Socioeconomic Factors
Register for Updates
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
NCT00673842
Recruiting
This study will assess whether an implantable defibrillator will increase the likelihood of survival in patients who have had a heart attack, have abnormal test results from a 24 hour heart monitor, and who have low normal heart function.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
03/01/2024
Locations: South Carolina Heart Center, Columbia, South Carolina
Conditions: Myocardial Infarction, Sudden Death
Register for Updates
Project: Every Child for Younger Patients With Cancer
NCT02402244
Recruiting
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Gender:
All
Ages:
25 years and below
Trial Updated:
02/27/2024
Locations: Prisma Health Richland Hospital, Columbia, South Carolina
Conditions: Central Nervous System Neoplasm, Childhood Immature Teratoma, Childhood Langerhans Cell Histiocytosis, Childhood Mature Teratoma, Congenital Mesoblastic Nephroma, Lymphoproliferative Disorder, Myeloproliferative Neoplasm, Stromal Neoplasm, Carcinoma In Situ, Malignant Solid Neoplasm, Desmoid Fibromatosis, Ganglioneuroma, Melanocytic Neoplasm, Neuroendocrine Neoplasm
Register for Updates
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
NCT01574053
Recruiting
Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and Australasia-while also expanding to include sites in Latin America. More than 30,000 participants have now enrolled into the study. With annual assessments and no end date, Enroll-HD has built a large and rich database of longitudinal clinical data and biospecimens that form the basis for studies developing tools and b... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/26/2024
Locations: University of South Carolina, Columbia, South Carolina
Conditions: Huntington's Disease
Register for Updates
A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN
NCT05856760
Recruiting
This is a 28-week, open-label, multicenter, single-group Phase 2 exploratory study to determine the safety and effect of sparsentan in participants with IgAN who are at risk of disease progression to kidney failure despite being on both stable RAASi and SGLT2 inhibitor treatment for at least 12 weeks prior to study entry
Gender:
All
Ages:
18 years and above
Trial Updated:
02/22/2024
Locations: Travere Investigational Site, Columbia, South Carolina
Conditions: Immunoglobulin A Nephropathy
Register for Updates
A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS
NCT06076499
Recruiting
Multi-center post-market, observational study to assess the long-term effectiveness and safety of the NTX100 TOMAC System for patients with Restless Legs Syndrome.
Gender:
All
Ages:
21 years and above
Trial Updated:
02/20/2024
Locations: Bogan Sleep Consultants, LLC, Columbia, South Carolina
Conditions: Restless Legs Syndrome
Register for Updates
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS)
NCT05174312
Recruiting
The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve DMS system to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve DMS can more efficiently decongest ADHF patients in comparison to Control Therapy.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/16/2024
Locations: Prisma Health, Columbia, South Carolina
Conditions: Acute Decompensated Heart Failure
Register for Updates